298. Hereditary pancreatitis Clinical trials / Disease details

Clinical trials : 95 /  Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142

  
1 trial found
No.TrialIDDate_
enrollment		Date_
registration		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT01146561
(ClinicalTrials.gov)		October 13, 201024/5/2010Safety And Efficacy Of Tanezumab In Patients With Chronic PancreatitisA PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF THE ANALGESIC EFFICACY AND SAFETY OF TANEZUMAB IN PATIENTS WITH CHRONIC PANCREATITISChronic PancreatitisBiological: Tanezumab;Other: PlaceboPfizerNULLTerminated18 Years99 YearsAll2Phase 2United States